Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.23B
Enterprise Value3.03B
P/E Ratio14.56
PEG Ratio0.24
Price/Sales Ratio3.97
Price/Book Ratio1.67
Enterprise/Revenue3.86
Enterprise/EBITDA12.99

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.27
Operating Margin0.3
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.11

Income Statement

Revenue1.04B
Revenue/Share2
Gross Profit803.62M
EBITDA281M
Net Income198.12M
Diluted EPS0.39

Balance Sheet

Total Cash510.87M
Total Cash/Share1.02
Total Debt2.41M
Total Debt/Equity0
Current Ratio15.41
Book Value Per Share4.76

Price History

52-Week Change15.74
52-Week High14.23
52-Week Low5.32
Moving Average 50 Days8.61
Moving Average 200 Days7.49

Statistics

Average Volume47.37M
Shares Outstanding503.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield3.78
Payout Ratio0.56
Last Split Factor17:10
Last Split DateMay 30, 2019
AD